Pharma Blames EU IVD Regulation For Clinical Trial Delays
Lack Of Coordination On Performance Study Applications Negatively Affecting Drug Trials
The challenges posed by the implementation of the EU IVD Regulation are having a negative impact on medicine trials using diagnostics. Many of such studies are currently stalled and research-based drug companies are calling on all partners to engage in dialog to find an urgent solution.
